Download presentation
Presentation is loading. Please wait.
Published byRhoda Gordon Modified over 9 years ago
1
PRACTICAL PHARMACOLOGY-1 (Po701) Third Year FACULTY OF PHARMACY Department of Pharmacology & Toxicology CAIRO UNIVERSITY شعارالكلية منارة التعليم الصيدلي في مصر ومحيطها الإقليمي
4
Why Ach contracts the skeletal muscle? Why carbachol contracts the skeletal muscle? Why K + contracts the skeletal muscle?
5
Aim: Determining the following properties of an unknown drug which causes skeletal muscle contraction: 1.Its susceptibility to destruction by cholinesterase enzyme (CE). 2.Its site of action (acts on Nm receptors or directly on the muscle).
6
Unknown drug Susceptibility to CE enzyme Action on Nm receptors Cholinester (e.g. Ach) ++ Carbamate ester (e.g. carbachol) _+ Direct skeletal muscle stimulant (e.g. K + ) __
7
☺ How to test for susceptibility of the drug to destruction by CE?
8
Using anti-cholinesterase drug: Incubate the muscle with PHYSOSTIGMINE (anti- cholinesterase) then add the drug: if it is hydrolysed by CEif it is not hydrolysed by CE PHYSOSTIGMINE will prevent its destruction ↑ its amount at receptor site potentiation of muscle response PHYSOSTIGMINE will not change muscle response
9
☺ How to find out the site of action of the drug?
10
Block Nm receptors by TUBOCURARINE (neuromuscular blocker), then add the drug: if it acts on Nm receptors muscle response will ↓ if it doesn't act on Nm receptors muscle response will not change
11
In this experiment: The muscle’s response to the drug before & after adding the experimental tools (PHYSOSTIGMINR, & TUBOCURARINE) is observed. Q. Can we add the SM dose as a reference dose only once at the beginning of the experiment? Ans. No, because the sensitivity of the muscle may change during the experiment leading to changes in muscle response.
12
0.2 U 0.4 U 0.8 U 0.2 U 0.2 AntiChEs ( Physostigmine ) 5 min. OFF + NO WASH after 0.2 NMB ( Tubocurarine ) 5 min. OFF + NO WASH after 1.Susceptibility to destruction by cholinesterase: Not susceptible 2.Site of action: Direct 1.Susceptibility to destruction by cholinesterase: Not susceptible 2.Site of action: Direct Unknown may be K+
13
0.2 U 0.4 U 0.8 U 0.2 U 0.2 AntiChEs ( Physostigmine ) 5 min. 0.2 NMB ( Tubocurarine ) 5 min. OFF + NO WASH after 1.Susceptibility to destruction by cholinesterase: Not susceptible 2.Site of action: Stimulates muscular N m receptors 1.Susceptibility to destruction by cholinesterase: Not susceptible 2.Site of action: Stimulates muscular N m receptors Unknown may be Carbachol
14
0.2 U 0.4 U 0.8 U 0.2 U 0.2 AntiChEs ( Physostigmine ) 5 min. 0.2 NMB ( Tubocurarine ) 5 min. OFF + NO WASH after 1.Susceptibility to destruction by cholinesterase: Susceptible 2.Site of action: Stimulates muscular N m receptors 1.Susceptibility to destruction by cholinesterase: Susceptible 2.Site of action: Stimulates muscular N m receptors Unknown may be ACh
15
AChCarbacholK+ After Physostigmine No change After Tubocurarine No change
19
29112014
20
29 11 2014 Type code Select Lab time
21
29 11 2014
22
Type your name your ID Press Start
25
Press Add Dose
26
25
27
Complete the D/R relationship for the given UNK. solution (3 graded doses only)
28
Effect of anticholinesterase “physostigmine ”: 1.Choose a submax. dose 2.Repeat addition of submax. dose after the D/R 3.Incubate rectus with “physostigmine” 4.Repeat addition of submax. on incubated rectus Physostigmine Tubocurarine Physostigmine
29
Effect of neuromuscular blocker “tubocurarine ” Repeat the previous steps but with “tubocurarine”
31
Press printer icon to print Write your conclusion in the printed chart
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.